Re Contract

RNS Number : 6019B

Galliford Try PLC

08 October 2015

 



GALLIFORD TRY APPOINTED TO £150 MILLION PROGRAMME AT LUTON AND DUNSTABLE UNIVERSITY HOSPITAL

Galliford Try plc, the housebuilding and construction group, announces that it has been appointed as preferred supply chain partner under the ProCure21+ framework to support the £150 million sitewide redevelopment of Luton and Dunstable University Hospital.    

Work will start immediately to deliver a new £6 million office block which is required to enable delivery of the main works.

The main programme, which will complete in 2019 includes a new £80 million 'Hot Block' for all critical care, surgery and other complex care procedures, replacing several wards and the site's energy centre and completely refurbishing the Emergency Department.  A key element of the scheme is to improve public facilities which includes expanding the car park provision which will improve the patients' experience when at the hospital.

Peter Truscott, Chief Executive of Galliford Try, commented: "This prestigious scheme is one of the largest on the ProCure21+ framework and is a fantastic win for our business.  Galliford Try has a growing presence in the healthcare market and this is an excellent opportunity to demonstrate our capability in delivering complex public sector healthcare projects."  

Galliford Try -                 Peter Truscott, Chief Executive               01895 855001

                                    Graham Prothero, Finance Director

Notes to Editors

Galliford Try plc is a leading UK housebuilding and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. The housebuilding business - through its Linden Homes brand - sells distinctive homes to the public and affordable homes to housing associations and local authority providers.  The construction business carries out building and infrastructure work across the UK with clients ranging from major Government departments through to regulated utilities and private sector companies. At the end of the financial year to 30 June 2015, the Group generated revenues of £2.3 billion. 

 

END

 

 

CNTUGGCUUUPAGRM